These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Rational basis for the development of new antiepileptic drugs. Mutani R; Cantello R; Gianelli M; Bettucci D Epilepsy Res Suppl; 1991; 3():23-8. PubMed ID: 1685649 [No Abstract] [Full Text] [Related]
5. The brain distribution of old and new antiepileptic drugs. Monaco F; Sechi G Epilepsy Res Suppl; 1991; 3():57-65. PubMed ID: 1777083 [No Abstract] [Full Text] [Related]
6. Applications of computer assisted quantum pharmacology calculations in devising anticonvulsant rational polypharmacy strategies. Weaver DF Epilepsy Res Suppl; 1996; 11():95-111. PubMed ID: 9294731 [No Abstract] [Full Text] [Related]
7. Benefit of combination therapy in epilepsy: a review of the preclinical evidence with levetiracetam. Kaminski RM; Matagne A; Patsalos PN; Klitgaard H Epilepsia; 2009 Mar; 50(3):387-97. PubMed ID: 18627416 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of polypharmacy: prediction of drug interactions. Mather GG; Levy RH Epilepsy Res Suppl; 1996; 11():113-21. PubMed ID: 9294732 [No Abstract] [Full Text] [Related]
9. Use of animal models in developing guiding principles for polypharmacy in epilepsy. Löscher W; Wauquier A Epilepsy Res Suppl; 1996; 11():61-5. PubMed ID: 9294728 [No Abstract] [Full Text] [Related]
10. Neurobiology as a basis for rational polypharmacy. Section overview for rational polypharmacy conference. Lothman EW Epilepsy Res Suppl; 1996; 11():3-7. PubMed ID: 9294724 [No Abstract] [Full Text] [Related]
12. Basic mechanisms of seizure propagation: targets for rational drug design and rational polypharmacy. Löscher W; Ebert U Epilepsy Res Suppl; 1996; 11():17-43. PubMed ID: 9294726 [No Abstract] [Full Text] [Related]
13. Old and new mechanisms of antiepileptic drug actions. Dichter MA Epilepsy Res Suppl; 1993; 10():9-17. PubMed ID: 8251108 [TBL] [Abstract][Full Text] [Related]
15. Seletracetam, a small molecule SV2A modulator for the treatment of epilepsy. Pollard JR Curr Opin Investig Drugs; 2008 Jan; 9(1):101-7. PubMed ID: 18183537 [TBL] [Abstract][Full Text] [Related]
16. Stiripentol. Vincent JC Epilepsy Res Suppl; 1991; 3():153-6. PubMed ID: 1777073 [No Abstract] [Full Text] [Related]
17. [Molecular structures of anticonvulsants: molecular neurobiology of epilepsy]. Böhme I; Lüddens H Pharm Unserer Zeit; 2007; 36(4):262-8. PubMed ID: 17623315 [No Abstract] [Full Text] [Related]
18. Is tolerance to antiepileptic drugs clinically relevant? Avanzini G Epilepsia; 2006 Aug; 47(8):1285-7. PubMed ID: 16922871 [No Abstract] [Full Text] [Related]
19. Clinical trials performed for the new drug approval process in the United States: standard methods and alternative methods. Browne TR Epilepsy Res Suppl; 1993; 10():31-44. PubMed ID: 8251105 [No Abstract] [Full Text] [Related]
20. Ralitoline. Anhut H; Satzinger G; von Hodenberg A Epilepsy Res Suppl; 1991; 3():141-5. PubMed ID: 1777070 [No Abstract] [Full Text] [Related] [Next] [New Search]